Citius Pharmaceuticals, Inc. (CTXR) Gross profit 2017–2019
Citius Pharmaceuticals, Inc. (CTXR) annual gross profit history from SEC filings — each fiscal year as reported.
$15,000FY2019 · since FY2017: $5,000 → $15,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | $15,000 | -40.0% |
| FY2018 | $25,000 | +400.0% |
| FY2017 | $5,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTXR financial trends
CTXR RevenueCTXR Net incomeCTXR Net marginCTXR Gross marginCTXR Operating incomeCTXR Operating marginCTXR Operating cash flowCTXR Free cash flowCTXR Capital expendituresCTXR Return on equityCTXR Stock buybacksCTXR Dividends paidCTXR Total assetsCTXR Total liabilitiesCTXR Shareholders’ equityCTXR overview →